Quality of life assessment in hematopoietic stem cell transplantation performed on thalassemia major patients

Pediatric Hematology and Oncology

Volumn 29, Issue 5, 2012, Pages 461-471

  Uygun, Vedat ^a   Tayfun, Funda ^a   Akcan, Mediha ^a   Karasu, Gulsun Tezcan ^a   Kupesiz, Alphan ^a   Hazar, Volkan ^a   Yeşilipek, Akif ^a  

^a AKDENIZ UNIVERSITY   (Turkey)

Author keywords

Hematopoietic stem cell transplantation; Quality of life; Thalassemia; Thalassemia major

Indexed keywords

DEFERASIROX; DEFERIPRONE; DEFEROXAMINE; IMMUNOSUPPRESSIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; BLOOD TRANSFUSION; CHILD; CHRONIC GRAFT VERSUS HOST DISEASE; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEVELOPING COUNTRY; FEMALE; HEMATOPOIETIC STEM CELL; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HLA MATCHING; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; IRON OVERLOAD; MALE; PATIENT COMPLIANCE; PHYSICAL ACTIVITY; PRESCHOOL CHILD; QUALITY OF LIFE; QUESTIONNAIRE; SCHOOL CHILD; THALASSEMIA MAJOR;

ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; MALE; QUALITY OF LIFE; QUESTIONNAIRES; TRANSPLANTATION, HOMOLOGOUS;

EID: 84864844169     PISSN: 08880018     EISSN: 15210669     Source Type: Journal    
DOI: 10.3109/08880018.2012.693577     Document Type: Article

References (27)

1. Telfer P, Constantinidou G, Andreou P, et al. Quality of life in thalassemia. Ann N Y Acad Sci. 2005;1054:273-282.
2. Yesilipek MA. Stem cell transplantation in hemoglobinopathies. Hemoglobin 2007;31:251-256.
3. De SimoneM, Verrotti A, Iughetti L, et al. Final height of thalassemic patients who underwent bone marrow transplantation during childhood. Bone Marrow Transplant. 2001;28:201-205.
4. Hazar V, Gungor O, Guven AG, et al. Renal function after hematopoietic stem cell transplantation in children. Pediatr Blood Cancer. 2009;53:197-202.
5. Li CK, Chik KW,Wong GW, et al. Growth and endocrine function following bonemarrow transplantation for thalassemiamajor. Pediatr Hematol Oncol. 2004;21:411-419.
6. Piga A, Longo F, Voi V, et al. Late effects of bone marrow transplantation for thalassemia. Ann N Y Acad Sci. 1998;850:294-299.
7. Rocha V,Wagner JE, Jr., Sobocinski KA, et al. Graft-versus-host disease in childrenwho have received a cord-blood or bonemarrow transplant from an HLA-identical sibling. Eurocord and International BoneMarrow Transplant RegistryWorking Committee on Alternative Donor and Stem Cell Sources. N Engl J Med. 2000;342:1846-1854.
8. Thomas ED, Buckner CD, Sanders JE, et al. Marrow transplantation for thalassaemia. Lancet 1982;2:227-229.
9. Caocci G, Efficace F, Ciotti F, et al. Prospective assessment of health-related quality of life in pediatric patients with beta-thalassemia following hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2011;17:861-866.
10. Cheuk DK,Mok AS, Lee AC, et al. Quality of life in patients with transfusion-dependent thalassemia after hematopoietic SCT. Bone Marrow Transplant. 2008;42:319-327.
11. Lucarelli G, Galimberti M, Giardini C, et al. Bonemarrow transplantation in thalassemia. The experience of Pesaro. Ann N Y Acad Sci. 1998;850:270-275.
12. HIPS 2008. Turkey Demographic and Health Survey.With the contributions of General Directorate of Mother and Child Health/Family Planning,Ministry of Health, TUBITAK, Ankara, Turkey. Available at: Http://www.hips.hacettepe.edu.tr/ eng/tdhs08/ AccessedMarch 1, 2009.
13. Cakin Memik N, Agaoglu B, Coskun A, Uneri OS, Karakaya I. [The validity and reliability of the Turkish Pediatric Quality of Life Inventory for children 13-18 years old]. Turk Psikiyatri Derg. 2007;18:353-363.
14. Uneri OS, Agaoglu B, Coskun A,Memik NC. Validity and reliability of Pediatric Quality of Life Inventory for 2- to 4-year-old and 5- to 7-year-old Turkish children. Qual Life Res. 2008;17:307-315.
15. Varni JW, Seid M, Rode CA.The PedsQL: Measurementmodel for the pediatric quality of life inventory. Med Care. 1999;37:126-139.
16. Development of the World Health Organization WHOQOL-BREF quality of life assessment. The WHOQOL Group. PsycholMed. 1998;28:551-558.
17. Eser E, Fidaner H, Fidaner C, et al. Psychometric properties of the WHOQOL-100 and WHOQOLBREF. J Psychiatry Psychol Psychopharmacol 1999;7:23-40.
18. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A longtermclinicopathologic study of 20 Seattle patients. Am JMed. 1980;69:204-217.
19. Caocci G, Pisu S, Argiolu F, et al. Decision-making in adult thalassemia patients undergoing unrelated bonemarrow transplantation: quality of life, communication and ethical issues. Bone Marrow Transplant. 2006;37:165-169.
20. Kocabas BA,Öztürk Z, Samur AA, et al. Endocrinological Late Effects on TransplantedThalassemia Major Patients. VII Turkish Pediatric Hematology Congress 2009.
21. Aydinok Y, Erermis S, Bukusoglu N, Yilmaz D, Solak U. Psychosocial implications of Thalassemia Major. Pediatr Int. 2005;47:84-89.
22. Angastiniotis M. The adolescent thalassemic. The complicant rebel. Minerva Pediatr. 2002;54:511-515.
23. Marinov BI, Terziyski KV, Sapunarova KG, Kostianev SS. Exercise performance in children with severe beta-thalassemia before and after transfusion. FoliaMed. (Plovdiv) 2008;50:48-54.
24. Mavrogeni S, Gotsis E, Verganelakis D, et al. Effect of iron overload on exercise capacity in thalassemic patients with heart failure. The international journal of cardiovascular imaging 2009;25:777-783.
25. Baird K, Cooke K, Schultz KR. Chronic graft-versus-host disease (GVHD) in children. Pediatr Clin North Am. 2010;57:297-322.
26. Pidala J, Anasetti C, Jim H. Quality of life after allogeneic hematopoietic cell transplantation. Blood 2009;114:7-19.
27. Wong FL, Francisco L, Togawa K, et al. Long-termrecovery after hematopoietic cell transplantation: Predictors of quality-of-life concerns. Blood 2010;115:2508-2519.